U.S. Markets closed

CBD Global Sciences Inc. (CBDNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2631+0.0110 (+4.34%)
At close: 2:54PM EDT

CBD Global Sciences Inc.

225 Union Boulevard
Suite 350
Lakewood, CO 80228
United States
303 919 2913

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Brad WyattCo-Founder, CEO, Pres & DirectorN/AN/A1969
Mr. Glenn DooleyCo-Founder, COO, Company Sec. & DirectorN/AN/A1969
Mr. Alexander McAulay BBA, CPA, CAChief Financial OfficerN/AN/A1984
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


CBD Global Sciences Inc., a consumer goods and farming company, engages in the production and extraction of cannabidiol (CBD) products. It provides biomass, CBD oil, and CBD oil products. The company sells its products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.

Corporate Governance

CBD Global Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.